Grifols SA (GRFS)
7.295
-0.10
(-1.42%)
USD |
NASDAQ |
Sep 18, 16:00
7.295
0.00 (0.00%)
After-Hours: 20:00
Grifols Cash from Operations (Quarterly) : 265.35M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 265.35M |
| March 31, 2026 | 128.69M |
| December 31, 2025 | 491.88M |
| September 30, 2025 | 378.43M |
| June 30, 2025 | 173.38M |
| March 31, 2025 | 142.58M |
| December 31, 2024 | 562.70M |
| September 30, 2024 | 326.04M |
| June 30, 2024 | 273.52M |
| March 31, 2024 | -179.42M |
| December 31, 2023 | 159.95M |
| September 30, 2023 | 161.94M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 214.00M |
| December 31, 2020 | 321.51M |
| September 30, 2020 | 358.28M |
| June 30, 2020 | 481.47M |
| Date | Value |
|---|---|
| March 31, 2020 | 116.08M |
| December 31, 2019 | 260.26M |
| September 30, 2019 | 213.18M |
| June 30, 2019 | 358.77M |
| March 31, 2019 | -190.44M |
| December 31, 2018 | 386.20M |
| September 30, 2018 | 183.71M |
| June 30, 2018 | 189.75M |
| March 31, 2018 | 113.93M |
| December 31, 2017 | 318.12M |
| September 30, 2017 | 221.22M |
| June 30, 2017 | 255.15M |
| March 31, 2017 | 154.95M |
| December 31, 2016 | 196.99M |
| September 30, 2016 | 228.85M |
| June 30, 2016 | 121.88M |
| March 31, 2016 | 64.31M |
| December 31, 2015 | 337.18M |
| September 30, 2015 | 205.30M |
| June 30, 2015 | 248.39M |
| March 31, 2015 | 38.36M |
| December 31, 2014 | 408.96M |
| September 30, 2014 | 340.54M |
| June 30, 2014 | 377.90M |
| March 31, 2014 | 171.09M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| argenx SE | -- |
| Evaxion AS | -- |
| Autolus Therapeutics Plc | -25.16M |
| Pharma Mar SA | 3.848M |
| Oryzon Genomics SA | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -156.60M |
| Cash from Financing (Quarterly) | -337.83M |
| Free Cash Flow | 738.77M |
| Free Cash Flow Per Share (Quarterly) | 0.1855 |
| Free Cash Flow to Equity (Quarterly) | 1.529B |
| Free Cash Flow to Firm (Quarterly) | 194.61M |
| Free Cash Flow Yield | 14.88% |